High EDSS can predict risk for upper urinary tract damage in patients with multiple sclerosis

Mult Scler. 2018 Apr;24(4):529-534. doi: 10.1177/1352458517703801. Epub 2017 Apr 3.

Abstract

Background: Neurogenic lower urinary tract dysfunction (NLUTD) is very common in patients with multiple sclerosis (MS), and it might jeopardize renal function and thereby increase mortality. Although there are well-known urodynamic risk factors for upper urinary tract damage, no clinical prediction parameters are available.

Objective: We aimed to assess clinical parameters potentially predicting urodynamic risk factors for upper urinary tract damage.

Methods: A consecutive series of 141 patients with MS referred from neurologists for primary neuro-urological work-up including urodynamics were prospectively evaluated. Clinical parameters taken into account were age, sex, duration, and clinical course of MS and Expanded Disability Status Scale (EDSS).

Results: Multivariate modeling revealed EDSS as a clinical parameter significantly associated with urodynamic risk factors for upper urinary tract damage (odds ratio = 1.34, 95% confidence interval (CI) = 1.06-1.71, p = 0.02). Using receiver operator characteristic (ROC) curves, an EDSS of 5.0 as cutoff showed a sensitivity of 86%-87% and a specificity of 52% for at least one urodynamic risk factor for upper urinary tract damage.

Conclusion: High EDSS is significantly associated with urodynamic risk factors for upper urinary tract damage and allows a risk-dependent stratification in daily neurological clinical practice to identify MS patients requiring further neuro-urological assessment and treatment.

Keywords: Expanded Disability Status Scale (EDSS); Multiple sclerosis (MS); detrusor sphincter dyssynergia (DSD); neuro-urology; neurogenic lower urinary tract dysfunction (NLUTD); overactive bladder; prospective study; vesico-uretero-renal reflux.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis / physiopathology*
  • Multiple Sclerosis / therapy
  • Risk Factors
  • Treatment Outcome
  • Urinary Bladder, Neurogenic / etiology
  • Urinary Bladder, Neurogenic / physiopathology*
  • Urinary Tract / physiopathology*
  • Urodynamics / physiology*